2016 No. 945
The Prison and Young Offender Institution (Amendment) (No. 2) Rules 2016
Made
Laid before Parliament
Coming into force
The Secretary of State makes the following Rules in exercise of the powers conferred by sections 47(1) and (3A) of the Prison Act 19521.
Citation and commencementI11
These Rules may be cited as the Prison and Young Offender Institution (Amendment) (No. 2) Rules 2016 and come into force on 17th October 2016.
Amendment of the Prison Rules 1999I22
1
Rule 2(1) (interpretation) of the Prison Rules 19992 is amended as follows.
2
In the definition of “specified drug”—
a
after “containing” insert “one or more of the following”;
b
at the end of sub-paragraph (h) omit “and”, and
c
after sub-paragraph (i) insert—
j
PB-22 (Quinolin-8-yl-1-pentyl-1H-indole-3-carboxylate);
k
5F-MDMB-PINACA (Methyl-[2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate]);
l
AB-CHMINACA (N-[-1-(Aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide);
m
5F-AMB (Methyl 2-({[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl}amino)-3-methylbutanoate);
n
AMB-FUBINACA (Methyl-2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamide)-3-methylbutanoate);
o
Etizolam (4-(2-Chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine);
p
ADB-CHMINACA (N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide);
Amendment of the Young Offender Institution Rules 2000I33
1
Rule 2(1) (interpretation) of the Young Offender Institution Rules 20003 is amended as follows.
2
In the definition of “specified drug”—
a
after “containing” insert “one or more of the following”;
b
at the end of sub-paragraph (h) omit “and”, and
c
after sub-paragraph (i) insert—
j
PB-22 (Quinolin-8-yl-1-pentyl-1H-indole-3-carboxylate);
k
5F-MDMB-PINACA (Methyl-[2-(1-(5-fluoropentyl)-1H-indazole-3-carboxamido)-3,3-dimethylbutanoate]);
l
AB-CHMINACA (N-[-1-(Aminocarbonyl)-2-methylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide);
m
5F-AMB (Methyl 2-({[1-(5-fluoropentyl)-1H-indazol-3-yl]carbonyl}amino)-3-methylbutanoate);
n
AMB-FUBINACA (Methyl-2-(1-(4-fluorobenzyl)-1H-indazole-3-carboxamide)-3-methylbutanoate);
o
Etizolam (4-(2-Chlorophenyl)-2-ethyl-9-methyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine);
p
ADB-CHMINACA (N-[1-(aminocarbonyl)-2,2-dimethylpropyl]-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide);
(This note is not part of the Rules)